US EditionAdvanced Heart, Kidney and Metabolic Disease Linked to Higher Cancer Risk
Cancer risk rose sharply in stage 3 and 4 CKM syndrome, with nearly 1.4 million Japanese insurance claims reviewed, researchers said.
- On April 27, 2026, researchers published a study in Circulation linking advanced CKM syndrome to higher cancer risk, analyzing insurance claims for nearly 1.4 million people in Japan.
- CKM syndrome represents a complex interplay where cardiovascular, kidney, and metabolic dysfunction exacerbate each other, categorized into stages ranging from stage 0 with no risk factors to stage 4 involving established cardiovascular disease.
- Study results show cancer risk increases sharply in later stages: stage 3 carries a 25% higher risk and stage 4 presents a 30% risk, whereas stage 1 or stage 2 faced a less than 5% chance of cancer diagnosis.
- Lead author Hidehiro Kaneko, M.D., Ph.D., noted doctors should consider cancer risk in CKM syndrome patients, while Tochukwu Okwuosa, D.O., an American Heart Association volunteer at Rush University Medical Center in Chicago, described the "bidirectional relationship" between conditions.
- Because the research is observational, it identifies associations rather than causality, and since the study focused on a homogenous Japanese population, further research is necessary to determine if results apply to the United States population.
12 Articles
12 Articles
Advanced heart, kidney and metabolic disease linked to higher cancer risk
People with advanced heart, kidney and metabolic disease may face a higher risk of developing cancer, according to new research published today in the American Heart Association's peer-reviewed scientific journal Circulation: Population Health and Outcomes.
Good Morning America
As heart, kidney and metabolic health worsen, cancer risk may rise: Study
As heart, kidney and metabolic problems build up to more advanced stages, a person's risk of developing several cancers rises sharply, a new study published Monday finds.
A comprehensive study of nearly 1.4 million people shows that those suffering from severe cardiovascular-renal-metabolic syndrome (CKM) have a significantly higher risk of developing cancer compared to those without risk factors. Chronic diseases rarely occur isolated. Most of the time, they are influenced and worsened [...]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
